Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMISE: Triptorelin for Prevention of Chemotherapy-induced Menopause in Breast Cancer
NCT00311636Phase 3Completed
- Sponsor
- Gruppo Italiano Mammella
- Start
- Sep 2003
- Primary completion
- Jan 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of triptorelin in menopause, sponsored by Gruppo Italiano Mammella. Started Sep 2003; status: completed.
02
Drugs
triptorelin
03
Conditions
menopause
Beyond the preview
Go deeper on NCT00311636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00311636.